Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
Peringkat dalam Saham
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Harga Saham
$6.17
Kapitalisasi Pasar
$3.52B
Perubahan (1 hari)
-0.05%
Perubahan (1 tahun)
-1.86%
Negara
CN
Perdagangan Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Kategori
Healthcare
Pendapatan untuk Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Pendapatan pada Oct 2026 TTM: 0
Menurut laporan keuangan terbaru dari Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, pendapatan saat ini (TTM) adalah 0. Pada tahun 2026, perusahaan menghasilkan pendapatan sebesar 0 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited dari 2001 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2025 | $702.84M | -29.79% |
| 2024 | $1.00B | -13.82% |
| 2023 | $1.16B | -2.87% |
| 2022 | $1.20B | 10.04% |
| 2021 | $1.09B | 7.51% |
| 2020 | $1.01B | 0.64% |
| 2019 | $1.00B | 8.65% |
| 2018 | $924.41M | 5.71% |
| 2017 | $874.43M | -2.75% |
| 2016 | $899.13M | -17.54% |
| 2015 | $1.09B | -4.70% |
| 2014 | $1.14B | 15.48% |
| 2013 | $990.83M | 20.44% |
| 2012 | $822.65M | 18.08% |
| 2011 | $696.67M | 32.38% |
| 2010 | $526.25M | 24.71% |
| 2009 | $421.97M | 21.73% |
| 2008 | $346.64M | 12.07% |
| 2007 | $309.30M | 11.54% |
| 2006 | $277.30M | -10.61% |
| 2005 | $310.21M | 21.98% |
| 2004 | $254.31M | 1.95% |
| 2003 | $249.43M | 12.25% |
| 2002 | $222.22M | 20.82% |
| 2001 | $183.92M | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
